$NGSX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeurogesX Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NeurogesX Inc. Get notifications about new insider transactions in NeurogesX Inc for free.
Page: < prev 1 2 3 4 5 5 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | A | 1.07 | 1,250 | 1,338 | 1,250 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | D | 11.25 | 5,000 | 56,250 | 0 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | A | 1.07 | 1,020 | 1,091 | 1,020 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | A | 1.07 | 3,063 | 3,277 | 3,063 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | D | 3.75 | 8,166 | 30,623 | 0 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | A | 1.07 | 12,177 | 13,029 | 12,177 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | D | 2.70 | 18,266 | 49,318 | 0 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | A | 1.07 | 12,177 | 13,029 | 12,177 | |
| Dec 14 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Exec. V.P., COO & C ... | Option Exercise | D | 2.70 | 18,266 | 49,318 | 0 | |
| Oct 27 2011 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Option Exercise | Z | 1.65 | 30,000 | 49,500 | 30,000 | |
| Sep 20 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | CMO, EVP Research & ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Sep 20 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Sep 20 2011 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Aug 12 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 2.00 | 82,109 | 164,571 | 0 | 82.1 K to 0 (-100.00 %) |
| Aug 12 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 2.15 | 81,359 | 175,174 | 82,109 | 163.5 K to 82.1 K (-49.77 %) |
| Aug 11 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.00 | 82,109 | 164,571 | 0 | 82.1 K to 0 (-100.00 %) | |
| Aug 11 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.15 | 81,359 | 175,174 | 82,109 | 163.5 K to 82.1 K (-49.77 %) | |
| Jul 26 2011 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 1.65 | 5,814 | 9,593 | 5,814 | |
| Jul 26 2011 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Grant | A | 1.65 | 11,627 | 19,185 | 21,748 | 10.1 K to 21.7 K (+114.88 %) |
| Jul 26 2011 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Option Exercise | A | 1.65 | 30,000 | 49,500 | 30,000 | |
| Jul 26 2011 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Grant | A | 1.65 | 60,000 | 99,000 | 75,000 | 15 K to 75 K (+400.00 %) |
| Jul 26 2011 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Option Exercise | A | 1.65 | 14,535 | 23,983 | 14,535 | |
| Jul 26 2011 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Grant | A | 1.65 | 29,069 | 47,964 | 53,540 | 24.5 K to 53.5 K (+118.79 %) |
| Jul 26 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Option Exercise | A | 1.65 | 14,535 | 23,983 | 14,535 | |
| Jul 26 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Grant | A | 1.65 | 29,069 | 47,964 | 64,877 | 35.8 K to 64.9 K (+81.18 %) |
| Jul 26 2011 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | P | 1.65 | 872,093 | 1,438,953 | 872,093 | |
| Jul 26 2011 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Buy | P | 1.65 | 1,744,186 | 2,877,907 | 4,187,777 | 2.4 M to 4.2 M (+71.38 %) |
| Jul 25 2011 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | P | 1.65 | 872,093 | 1,438,953 | 872,093 | |
| Jul 25 2011 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Buy | P | 1.65 | 1,744,186 | 2,877,907 | 4,187,777 | 2.4 M to 4.2 M (+71.38 %) |
| Jun 28 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.10 | 1,079 | 2,271 | 163,468 | 164.5 K to 163.5 K (-0.66 %) | |
| Jun 28 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.10 | 7,499 | 15,753 | 164,547 | 172 K to 164.5 K (-4.36 %) | |
| Jun 28 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 2.10 | 1,079 | 2,271 | 163,468 | 164.5 K to 163.5 K (-0.66 %) |
| Jun 28 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 2.10 | 7,499 | 15,753 | 164,547 | 172 K to 164.5 K (-4.36 %) |
| Jun 27 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 2.09 | 50,000 | 104,535 | 172,046 | 222 K to 172 K (-22.52 %) |
| Jun 27 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.09 | 50,000 | 104,535 | 172,046 | 222 K to 172 K (-22.52 %) | |
| Jun 20 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 3.20 | 300,000 | 961,380 | 222,046 | 522 K to 222 K (-57.47 %) |
| Jun 20 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 3.20 | 300,000 | 961,380 | 222,046 | 522 K to 222 K (-57.47 %) | |
| Jun 20 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.95 | 80,192 | 236,438 | 129,437 | 209.6 K to 129.4 K (-38.25 %) | |
| Jun 20 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.95 | 18,810 | 55,459 | 33,332 | 52.1 K to 33.3 K (-36.07 %) | |
| Jun 06 2011 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
| Jun 06 2011 | NGSX | NeurogesX Inc | Nelson Steven H | Director | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
| Jun 06 2011 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
| Jun 06 2011 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
| Jun 06 2011 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
| Jun 06 2011 | NGSX | NeurogesX Inc | Orwin John A | Director | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
| Jun 06 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.22 | 3,300 | 7,326 | 209,629 | 212.9 K to 209.6 K (-1.55 %) | |
| Jun 06 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.36 | 14,425 | 34,101 | 212,929 | 227.4 K to 212.9 K (-6.34 %) | |
| Jun 06 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.36 | 3,382 | 7,995 | 52,142 | 55.5 K to 52.1 K (-6.09 %) | |
| Jun 02 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.46 | 8,910 | 21,889 | 227,354 | 236.3 K to 227.4 K (-3.77 %) | |
| Jun 02 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 2.46 | 2,090 | 5,135 | 55,524 | 57.6 K to 55.5 K (-3.63 %) | |
| May 19 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.82 | 1,115 | 3,144 | 4,999 | 6.1 K to 5 K (-18.24 %) |
| May 19 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.73 | 1,333 | 3,639 | 6,114 | 7.4 K to 6.1 K (-17.90 %) |
| May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.84 | 1,333 | 3,786 | 7,447 | 8.8 K to 7.4 K (-15.18 %) |
| May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.81 | 733 | 2,060 | 7,447 | 8.2 K to 7.4 K (-8.96 %) |
| May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.91 | 600 | 1,746 | 8,180 | 8.8 K to 8.2 K (-6.83 %) |
| May 10 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Buy | P | 3.02 | 1,500 | 4,524 | 2,500 | 1,000 to 2.5 K (+150.00 %) |
| May 10 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Buy | P | 3.04 | 1,600 | 4,864 | 2,600 | 1,000 to 2.6 K (+160.00 %) |
| May 10 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Buy | P | 3.03 | 1,500 | 4,539 | 2,500 | 1,000 to 2.5 K (+150.00 %) |
| May 10 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Buy | P | 3.03 | 1,500 | 4,539 | 2,500 | 1,000 to 2.5 K (+150.00 %) |
| Apr 29 2011 | NGSX | NeurogesX Inc | LYONS GARY A | Director | Option Exercise | A | 3.29 | 100,000 | 329,000 | 100,000 | |
| Apr 29 2011 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Option Exercise | A | 3.29 | 75,000 | 246,750 | 75,000 | |
| Apr 29 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 3.29 | 75,000 | 246,750 | 75,000 | |
| Apr 29 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Option Exercise | A | 3.29 | 75,000 | 246,750 | 75,000 | |
| Mar 28 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 4.02 | 120,000 | 482,940 | 522,046 | 642 K to 522 K (-18.69 %) | |
| Mar 28 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 4.07 | 32,600 | 132,610 | 642,046 | 674.6 K to 642 K (-4.83 %) | |
| Mar 28 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 4.02 | 120,000 | 482,940 | 522,046 | 642 K to 522 K (-18.69 %) |
| Mar 28 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 4.07 | 32,600 | 132,610 | 642,046 | 674.6 K to 642 K (-4.83 %) |
| Mar 25 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 4.01 | 12,100 | 48,537 | 674,646 | 686.7 K to 674.6 K (-1.76 %) | |
| Mar 25 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 4.00 | 4,125 | 16,519 | 60,077 | 64.2 K to 60.1 K (-6.43 %) | |
| Mar 25 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 4.00 | 17,575 | 70,379 | 246,117 | 263.7 K to 246.1 K (-6.66 %) | |
| Mar 25 2011 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Sell | S | 4.01 | 12,100 | 48,537 | 674,646 | 686.7 K to 674.6 K (-1.76 %) |
| Feb 10 2011 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO & Di ... | Gift | G | 0.00 | 5,000 | 0 | 96,000 | 101 K to 96 K (-4.95 %) |
| Mar 02 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 3.53 | 6,806 | 24,048 | 263,692 | 270.5 K to 263.7 K (-2.52 %) | |
| Mar 02 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 3.53 | 1,494 | 5,279 | 64,202 | 65.7 K to 64.2 K (-2.27 %) | |
| Mar 02 2011 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 3.87 | 5,808 | 22,453 | 65,696 | 71.5 K to 65.7 K (-8.12 %) | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 5.06 | 125,000 | 632,500 | 125,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 5.06 | 25,000 | 126,500 | 25,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Rinne Susan P | Vice President, Reg ... | Option Exercise | A | 5.06 | 20,000 | 101,200 | 20,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Rinne Susan P | Vice President, Reg ... | Option Exercise | A | 5.06 | 12,500 | 63,250 | 12,500 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Option Exercise | A | 5.06 | 110,000 | 556,600 | 110,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Option Exercise | A | 5.06 | 22,500 | 113,850 | 22,500 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Kawahata Russell T | VP, Pharmaceutical ... | Option Exercise | A | 5.06 | 20,000 | 101,200 | 20,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Kawahata Russell T | VP, Pharmaceutical ... | Option Exercise | A | 5.06 | 12,500 | 63,250 | 12,500 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Option Exercise | A | 5.06 | 130,000 | 657,800 | 130,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | EVP, COO & CFO | Option Exercise | A | 5.06 | 25,000 | 126,500 | 25,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO & Di ... | Option Exercise | A | 5.06 | 125,000 | 632,500 | 125,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO & Di ... | Option Exercise | A | 5.06 | 30,000 | 151,800 | 30,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Bley Keith R | SVP, Nonclinical R ... | Option Exercise | A | 5.06 | 20,000 | 101,200 | 20,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Bley Keith R | SVP, Nonclinical R ... | Option Exercise | A | 5.06 | 12,500 | 63,250 | 12,500 | |
| Jan 20 2011 | NGSX | NeurogesX Inc | DiTonno Anthony A | President and CEO | Gift | G | 0.00 | 4,000 | 0 | 101,000 | 105 K to 101 K (-3.81 %) |
| Nov 19 2010 | NGSX | NeurogesX Inc | Nelson Steven H | Director | Option Exercise | A | 6.00 | 20,000 | 120,000 | 20,000 | |
| Sep 13 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 5.50 | 30,000 | 165,000 | 2,648,107 | 2.6 M to 2.6 M (+1.15 %) |
| Aug 20 2010 | NGSX | NeurogesX Inc | Markels Michael | Senior VP,Commercia ... | Buy | P | 5.75 | 2,500 | 14,370 | 21,805 | 19.3 K to 21.8 K (+12.95 %) |
| Aug 11 2010 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Buy | P | 6.03 | 5,000 | 30,155 | 15,000 | 10 K to 15 K (+50.00 %) |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 6.39 | 4,100 | 26,197 | 270,498 | 266.4 K to 270.5 K (+1.54 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 6.65 | 10,501 | 69,851 | 266,398 | 255.9 K to 266.4 K (+4.10 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.16 | 7,000 | 50,150 | 71,504 | 64.5 K to 71.5 K (+10.85 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 9.94 | 5,217 | 51,863 | 64,504 | 59.3 K to 64.5 K (+8.80 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 9.44 | 12,000 | 113,328 | 255,897 | 243.9 K to 255.9 K (+4.92 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 9.51 | 8,000 | 76,082 | 243,897 | 235.9 K to 243.9 K (+3.39 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.26 | 10,000 | 72,583 | 235,897 | 225.9 K to 235.9 K (+4.43 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.28 | 33,700 | 245,279 | 686,746 | 653 K to 686.7 K (+5.16 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.20 | 2,000 | 14,405 | 225,897 | 223.9 K to 225.9 K (+0.89 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.20 | 500 | 3,601 | 223,897 | 223.4 K to 223.9 K (+0.22 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.06 | 5,521 | 38,995 | 653,046 | 647.5 K to 653 K (+0.85 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.09 | 2,500 | 17,730 | 647,525 | 645 K to 647.5 K (+0.39 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.66 | 5,000 | 38,318 | 645,025 | 640 K to 645 K (+0.78 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.81 | 2,400 | 18,735 | 640,025 | 637.6 K to 640 K (+0.38 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.60 | 2,500 | 19,011 | 637,625 | 635.1 K to 637.6 K (+0.39 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.37 | 3,100 | 22,847 | 635,125 | 632 K to 635.1 K (+0.49 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.82 | 3,600 | 28,138 | 632,025 | 628.4 K to 632 K (+0.57 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.79 | 5,600 | 43,647 | 628,425 | 622.8 K to 628.4 K (+0.90 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.76 | 8,000 | 62,073 | 622,825 | 614.8 K to 622.8 K (+1.30 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.44 | 10,000 | 74,448 | 614,825 | 604.8 K to 614.8 K (+1.65 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.55 | 7,600 | 57,363 | 604,825 | 597.2 K to 604.8 K (+1.27 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.53 | 8,000 | 60,224 | 597,225 | 589.2 K to 597.2 K (+1.36 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.89 | 35,000 | 276,290 | 589,225 | 554.2 K to 589.2 K (+6.32 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.30 | 7,800 | 64,726 | 223,397 | 215.6 K to 223.4 K (+3.62 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.31 | 7,000 | 58,197 | 554,225 | 547.2 K to 554.2 K (+1.28 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.32 | 2,200 | 18,300 | 59,287 | 57.1 K to 59.3 K (+3.85 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.32 | 2,000 | 16,646 | 57,087 | 55.1 K to 57.1 K (+3.63 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.31 | 7,600 | 63,142 | 547,225 | 539.6 K to 547.2 K (+1.41 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.07 | 20,000 | 161,458 | 539,625 | 519.6 K to 539.6 K (+3.85 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.40 | 3,339 | 28,048 | 215,597 | 212.3 K to 215.6 K (+1.57 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.71 | 13,600 | 118,504 | 519,625 | 506 K to 519.6 K (+2.69 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.41 | 15,000 | 126,192 | 506,025 | 491 K to 506 K (+3.05 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.30 | 53,000 | 439,651 | 491,025 | 438 K to 491 K (+12.10 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.51 | 36,323 | 309,094 | 438,025 | 401.7 K to 438 K (+9.04 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 9.08 | 70,200 | 637,486 | 212,258 | 142.1 K to 212.3 K (+49.42 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 9.10 | 19,800 | 180,200 | 55,087 | 35.3 K to 55.1 K (+56.11 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 8.38 | 678 | 5,682 | 35,287 | 36 K to 35.3 K (-1.89 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 8.30 | 11,400 | 94,620 | 142,058 | 153.5 K to 142.1 K (-7.43 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 8.28 | 3,223 | 26,686 | 35,965 | 39.2 K to 36 K (-8.22 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 8.42 | 3,080 | 25,934 | 153,458 | 156.5 K to 153.5 K (-1.97 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 8.40 | 1,320 | 11,088 | 39,188 | 40.5 K to 39.2 K (-3.26 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Sell | S | 8.32 | 6,684 | 55,639 | 156,538 | 163.2 K to 156.5 K (-4.10 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.85 | 4,472 | 35,115 | 163,222 | 158.8 K to 163.2 K (+2.82 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.96 | 2,862 | 22,780 | 40,508 | 37.6 K to 40.5 K (+7.60 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.96 | 10,000 | 79,593 | 158,750 | 148.8 K to 158.8 K (+6.72 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.11 | 2,600 | 21,090 | 148,750 | 146.2 K to 148.8 K (+1.78 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.13 | 650 | 5,286 | 37,646 | 37 K to 37.6 K (+1.76 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.15 | 7,017 | 57,153 | 146,150 | 139.1 K to 146.2 K (+5.04 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.17 | 1,754 | 14,321 | 36,996 | 35.2 K to 37 K (+4.98 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.02 | 513 | 4,114 | 35,242 | 34.7 K to 35.2 K (+1.48 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.00 | 2,033 | 16,264 | 139,133 | 137.1 K to 139.1 K (+1.48 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.36 | 41,865 | 350,163 | 137,100 | 95.2 K to 137.1 K (+43.96 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.38 | 10,466 | 87,721 | 34,729 | 24.3 K to 34.7 K (+43.14 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 8.00 | 4,263 | 34,113 | 24,263 | 20 K to 24.3 K (+21.32 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.98 | 17,055 | 136,135 | 95,235 | 78.2 K to 95.2 K (+21.82 %) | |
| Jul 29 2010 | NGSX | NeurogesX Inc | BREEN DORON | Buy | P | 7.69 | 88,000 | 676,720 | 401,702 | 313.7 K to 401.7 K (+28.05 %) |